This is an excellent combination for those looking to support their physical stamina and heart health
GLP-1 Ozempic/Mounjaro 22.7% CagriSema (REDEFINE-1, 68 ) incretin- 10.8% 26 (Phase 2, Lancet 2021) 2 : 15.6% , 2.2% HbA1c semaglutide ( ) 16 , half-life ~7 - 2 ( REDEFINE-2) / GLP-1 GLP-1 (Ozempic/Mounjaro) cagrilintide +610% , GLP-1 + cagrilintide 2 semaglutide- / advanced users, CagriSema- () , GLP-1 16 (Novo Nordisk Phase 3 CagriSema): 14: 0.25 / 1 /
But healthcare providers may recommend that you change food choices, stress management techniques and medication to reduce symptoms
The dose-response relationship demonstrates that higher doses produce greater reductions in HbA1c and body weight, with clinical effects sustained over long-term treatment (Davies et al., 2021)
As scientists continue to explore the mechanisms and long-term effects of this peptide, Epithalon stands out as a key player in the quest to understand and address the complex challenges of aging